Johannes Riegler1, Astrid Gillich1, Qi Shen1, Joseph D Gold1, Joseph C Wu2. 1. From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA. 2. From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA. joewu@stanford.edu.
Abstract
BACKGROUND: Cell therapies offer the potential to improve cardiac function after myocardial infarction. Although injection of single-cell suspensions has proven safe, cell retention and survival rates are low. Tissue-engineered grafts allow cell delivery with minimal initial cell loss and mechanical support to the heart. However, graft performance cannot be easily compared, and optimal construct thickness, vascularization, and survival kinetics are unknown. METHODS AND RESULTS: Cardiac tissue slices (CTS) were generated by sectioning mouse hearts (n=40) expressing firefly luciferase and green fluorescent protein into slices of defined size and thickness using a vibrating blade microtome. Bioluminescence imaging of CTS transplanted onto hearts of immunodeficient mice demonstrated survival of ≤30% of transplanted cells. Cardiac slice perfusion was re-established within 3 days, likely through anastomosis of pre-existing vessels with the host vasculature and invasion of vessels from the host. Immunofluorescence showed a peak in cell death 3 days after transplantation and a gradual decline thereafter. MRI revealed preservation of contractile function and an improved ejection fraction 1 month after transplantation of CTS (28±2% CTS versus 22±2% control; P=0.05). Importantly, this effect was specific to CTS because transplantation of skeletal muscle tissue slices led to faster dilative remodeling and higher animal mortality. CONCLUSIONS: In summary, this is the first study to use CTS as a benchmark to validate and model tissue-engineered graft studies. CTS transplantation improved cell survival, established reperfusion, and enhanced cardiac function after myocardial infarction. These findings also confirm that dilative remodeling can be attenuated by topical transplantation of CTS but not skeletal muscle tissue grafts.
BACKGROUND: Cell therapies offer the potential to improve cardiac function after myocardial infarction. Although injection of single-cell suspensions has proven safe, cell retention and survival rates are low. Tissue-engineered grafts allow cell delivery with minimal initial cell loss and mechanical support to the heart. However, graft performance cannot be easily compared, and optimal construct thickness, vascularization, and survival kinetics are unknown. METHODS AND RESULTS: Cardiac tissue slices (CTS) were generated by sectioning mouse hearts (n=40) expressing firefly luciferase and green fluorescent protein into slices of defined size and thickness using a vibrating blade microtome. Bioluminescence imaging of CTS transplanted onto hearts of immunodeficient mice demonstrated survival of ≤30% of transplanted cells. Cardiac slice perfusion was re-established within 3 days, likely through anastomosis of pre-existing vessels with the host vasculature and invasion of vessels from the host. Immunofluorescence showed a peak in cell death 3 days after transplantation and a gradual decline thereafter. MRI revealed preservation of contractile function and an improved ejection fraction 1 month after transplantation of CTS (28±2% CTS versus 22±2% control; P=0.05). Importantly, this effect was specific to CTS because transplantation of skeletal muscle tissue slices led to faster dilative remodeling and higher animal mortality. CONCLUSIONS: In summary, this is the first study to use CTS as a benchmark to validate and model tissue-engineered graft studies. CTS transplantation improved cell survival, established reperfusion, and enhanced cardiac function after myocardial infarction. These findings also confirm that dilative remodeling can be attenuated by topical transplantation of CTS but not skeletal muscle tissue grafts.
Authors: J Leor; S Aboulafia-Etzion; A Dar; L Shapiro; I M Barbash; A Battler; Y Granot; S Cohen Journal: Circulation Date: 2000-11-07 Impact factor: 29.690
Authors: Koen E A van der Bogt; Ahmad Y Sheikh; Sonja Schrepfer; Grant Hoyt; Feng Cao; Katherine J Ransohoff; Rutger-Jan Swijnenburg; Jeremy Pearl; Andrew Lee; Michael Fischbein; Christopher H Contag; Robert C Robbins; Joseph C Wu Journal: Circulation Date: 2008-09-30 Impact factor: 29.690
Authors: Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng Journal: Nat Neurosci Date: 2009-12-20 Impact factor: 24.884
Authors: Juan C Chachques; Jorge C Trainini; Noemi Lago; Miguel Cortes-Morichetti; Olivier Schussler; Alain Carpentier Journal: Ann Thorac Surg Date: 2008-03 Impact factor: 4.330
Authors: Kazuro L Fujimoto; Kimimasa Tobita; W David Merryman; Jianjun Guan; Nobuo Momoi; Donna B Stolz; Michael S Sacks; Bradley B Keller; William R Wagner Journal: J Am Coll Cardiol Date: 2007-05-25 Impact factor: 24.094
Authors: K R Stevens; K L Kreutziger; S K Dupras; F S Korte; M Regnier; V Muskheli; M B Nourse; K Bendixen; H Reinecke; C E Murry Journal: Proc Natl Acad Sci U S A Date: 2009-09-17 Impact factor: 11.205
Authors: Alexander R Pinto; Rosa Paolicelli; Ekaterina Salimova; Janko Gospocic; Esfir Slonimsky; Daniel Bilbao-Cortes; James W Godwin; Nadia A Rosenthal Journal: PLoS One Date: 2012-05-10 Impact factor: 3.240
Authors: Renganaden Sooppan; Samantha J Paulsen; Jason Han; Anderson H Ta; Patrick Dinh; Ann C Gaffey; Chantel Venkataraman; Alen Trubelja; George Hung; Jordan S Miller; Pavan Atluri Journal: Tissue Eng Part C Methods Date: 2015-12-14 Impact factor: 3.056
Authors: Johannes Riegler; Malte Tiburcy; Antje Ebert; Evangeline Tzatzalos; Uwe Raaz; Oscar J Abilez; Qi Shen; Nigel G Kooreman; Evgenios Neofytou; Vincent C Chen; Mouer Wang; Tim Meyer; Philip S Tsao; Andrew J Connolly; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu Journal: Circ Res Date: 2015-08-19 Impact factor: 17.367
Authors: Yasuhiro Shudo; Andrew B Goldstone; Jeffrey E Cohen; Jay B Patel; Michael S Hopkins; Amanda N Steele; Bryan B Edwards; Masashi Kawamura; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2017-05-24 Impact factor: 5.209
Authors: Sangkyun Cho; Chelsea Lee; Mark A Skylar-Scott; Sarah C Heilshorn; Joseph C Wu Journal: J Mol Cell Cardiol Date: 2021-04-22 Impact factor: 5.000